Core Viewpoint - The article discusses the upcoming large-scale procurement of medical consumables for hard brain (spinal) membrane patches in the Beijing-Tianjin-Hebei region, highlighting the innovative products developed by Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. and their competitive advantages in the market [2][4][16]. Group 1: Procurement Announcement - The Tianjin Medical Procurement Center announced the initiation of a large-scale procurement for hard brain (spinal) membrane patches, requiring public medical institutions to participate [2]. - The procurement will cover products registered as medical devices in China, specifically those classified under the National Medical Insurance Bureau's code C040301118 [2]. Group 2: Product Development and Innovation - Guangzhou Maipu has focused on the innovation of biomaterials, successfully developing two products: Rui Mo® absorbable hard brain (spinal) membrane patch and Rui Kang® hard brain (spinal) membrane patch using polylactic acid and additive manufacturing technology [5][7]. - Rui Mo® is noted as the first successfully industrialized bio-additive manufactured artificial hard brain (spinal) membrane in China, recognized in the Ministry of Science and Technology's 2018 list of innovative medical device products [7]. Group 3: Product Advantages - The brain membrane product series has undergone over ten years of clinical testing, establishing itself as a trusted choice in neurosurgery due to its technological biomimicry, safety, and advanced manufacturing processes [9]. - The products support both suturing and adhesive application methods, enhancing surgical efficiency and adaptability to different clinical scenarios [10]. - The use of non-animal-derived materials minimizes virus risks, and the products are designed to degrade in line with tissue repair, reducing the risk of long-term complications [12]. Group 4: Competitive Bidding Advantages - In the upcoming procurement, Maipu's brain membrane products demonstrate significant bidding advantages, including dual certification for both Rui Mo® and Rui Kang®, ensuring reliability and stability compared to competitors with single certifications [14]. - The product range covers various sizes and price points, accommodating different clinical needs and cost control objectives, from small area to large area applications [17]. - The procurement process for the Beijing-Tianjin-Hebei "3+N" alliance has begun, with Maipu's products entering a critical market validation phase [16].